Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
Work underway on new semaglutide implant | FDA approves dual-energy ablation tech | Why DAPT after PCI is still a good idea
Thursday, July 9, 2026
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

Work underway on new semaglutide implant—no needles or pills required

The long-lasting implant could help patients benefit from semaglutide therapy without needing to take the drug on a daily basis. 

READ MORE >
overweight patient seeking health advice
Share on Twitter Share on Facebook Share on Linkedin

Work underway on new semaglutide implant—no needles or pills required

Share on Twitter Share on Facebook Share on Linkedin
overweight patient seeking health advice
The long-lasting implant could help patients benefit from semaglutide therapy without needing to take the drug on a daily basis. 
READ MORE >

FDA approves dual-energy ablation tech from Johnson & Johnson

The new Dual-Energy ThermoCool SmartTouch SF Platform delivers RF and PF energy through a single catheter. 

READ MORE >
Johnson & Johnson Dual-Energy ThermoCool SmartTouch SF platform
Share on Twitter Share on Facebook Share on Linkedin

FDA approves dual-energy ablation tech from Johnson & Johnson

Share on Twitter Share on Facebook Share on Linkedin
Johnson & Johnson Dual-Energy ThermoCool SmartTouch SF platform
The new Dual-Energy ThermoCool SmartTouch SF Platform delivers RF and PF energy through a single catheter. 
READ MORE >

Why DAPT with aspirin after PCI is still a good idea

Immediate aspirin discontinuation after PCI is associated with an increased risk of ischemic events, according to a new analysis of nearly 8,000 patients.

READ MORE >
doctor patient elderly check up hospital
Share on Twitter Share on Facebook Share on Linkedin

Why DAPT with aspirin after PCI is still a good idea

Share on Twitter Share on Facebook Share on Linkedin
doctor patient elderly check up hospital
Immediate aspirin discontinuation after PCI is associated with an increased risk of ischemic events, according to a new analysis of nearly 8,000 patients.
READ MORE >

Featured Articles

ACC takes on DOAC use with new scientific statement

Direct oral anticoagulants continue to be underutilized and inappropriately dosed. The American College of Cardiology hopes a new scientific statement can help address those issues and provide clinicians with an updated look at this important topic.

READ MORE >
Rivaroxaban (Xarelto) is among the direct oral anticoagulants (DOACs) including in the new 2026 ACC consensus statement on the use of DOACs.
Share on Twitter Share on Facebook Share on Linkedin

ACC takes on DOAC use with new scientific statement

Share on Twitter Share on Facebook Share on Linkedin
Rivaroxaban (Xarelto) is among the direct oral anticoagulants (DOACs) including in the new 2026 ACC consensus statement on the use of DOACs.
Direct oral anticoagulants continue to be underutilized and inappropriately dosed. The American College of Cardiology hopes a new scientific statement can help address those issues and provide clinicians with an updated look at this important topic.
READ MORE >

FDA approves labeling change for Gore EVAR devices

The updated labeling comes after the devices were found to be both safe and effective for the treatment of ruptured aneurysms. 

READ MORE >
Gore Excluder Conformable AAA Endoprosthesis
Share on Twitter Share on Facebook Share on Linkedin

FDA approves labeling change for Gore EVAR devices

Share on Twitter Share on Facebook Share on Linkedin
Gore Excluder Conformable AAA Endoprosthesis
The updated labeling comes after the devices were found to be both safe and effective for the treatment of ruptured aneurysms. 
READ MORE >

Exploring key breakthroughs in VT ablation

Today's sophisticated mapping systems allow clinicians to visualize VT circuits with unprecedented detail.

READ MORE >
Roderick Tung, MD, FACC, FHRS, tenured professor of medicine, chief of cardiology, University of Arizona College of Medicine, director, Banner Heart Institute, explained new technology opportunities in ventricular ablation.
Share on Twitter Share on Facebook Share on Linkedin

Exploring key breakthroughs in VT ablation

Share on Twitter Share on Facebook Share on Linkedin
Roderick Tung, MD, FACC, FHRS, tenured professor of medicine, chief of cardiology, University of Arizona College of Medicine, director, Banner Heart Institute, explained new technology opportunities in ventricular ablation.
Today's sophisticated mapping systems allow clinicians to visualize VT circuits with unprecedented detail.
READ MORE >

Why cardiology leaders should be careful about the quality metrics they focus on

"Data should simply be a measure of a broader organizational objective," one expert explained. "When the data becomes the goal, that's where organizations can get into trouble."

READ MORE >
Healthcare organizations have unprecedented access to clinical and operational data, but that abundance of information can become a liability if leaders lose sight of what those metrics are intended to accomplish, explained Joel Sauer, MBA, executive vice president of consulting at MedAxiom, an American College of Cardiology (ACC) company.
Share on Twitter Share on Facebook Share on Linkedin

Why cardiology leaders should be careful about the quality metrics they focus on

Share on Twitter Share on Facebook Share on Linkedin
Healthcare organizations have unprecedented access to clinical and operational data, but that abundance of information can become a liability if leaders lose sight of what those metrics are intended to accomplish, explained Joel Sauer, MBA, executive vice president of consulting at MedAxiom, an American College of Cardiology (ACC) company.
"Data should simply be a measure of a broader organizational objective," one expert explained. "When the data becomes the goal, that's where organizations can get into trouble."
READ MORE >

In Case You Missed It

CMS proposes major TAVR changes, including Medicare coverage for asymptomatic patients

After months of consideration, CMS has proposed sweeping changes to its TAVR coverage policies. The agency is accepting public comments until July 15.

READ MORE >
2024 has been a banner year for structural heart treatments, especially those focused on the tricuspid valve. In February, for example, Edwards Lifesciences made history when its Evoque transcatheter tricuspid valve replacement (TTVR) system became the first device of its kind to gain U.S. Food and Drug Administration (FDA) approval for treating tricuspid regurgitation (TR). Two months later, Abbott’s TriClip transcatheter edge-to-edge repair (TEER) system also gained FDA approval for the treatment of TR.
Share on Twitter Share on Facebook Share on Linkedin

CMS proposes major TAVR changes, including Medicare coverage for asymptomatic patients

Share on Twitter Share on Facebook Share on Linkedin
2024 has been a banner year for structural heart treatments, especially those focused on the tricuspid valve. In February, for example, Edwards Lifesciences made history when its Evoque transcatheter tricuspid valve replacement (TTVR) system became the first device of its kind to gain U.S. Food and Drug Administration (FDA) approval for treating tricuspid regurgitation (TR). Two months later, Abbott’s TriClip transcatheter edge-to-edge repair (TEER) system also gained FDA approval for the treatment of TR.
After months of consideration, CMS has proposed sweeping changes to its TAVR coverage policies. The agency is accepting public comments until July 15.
READ MORE >

'Not sustainable': The real impact of RVU cuts in electrophysiology

Despite a substantial increase in demand for electrophysiologists, payments for their services have remained stagnant. 

READ MORE >
Joshua R. Silverstein, MD, FHRS, a cardiac electrophysiologist at Allegheny Health Network Cardiovascular Institute, explains the real-world impacts of Centers of Medicare and Medicaid Services (CMS) RVU cuts in electrophysiology.
Share on Twitter Share on Facebook Share on Linkedin

'Not sustainable': The real impact of RVU cuts in electrophysiology

Share on Twitter Share on Facebook Share on Linkedin
Joshua R. Silverstein, MD, FHRS, a cardiac electrophysiologist at Allegheny Health Network Cardiovascular Institute, explains the real-world impacts of Centers of Medicare and Medicaid Services (CMS) RVU cuts in electrophysiology.
Despite a substantial increase in demand for electrophysiologists, payments for their services have remained stagnant. 
READ MORE >

Family files $17M lawsuit after young girl’s heart valve allegedly implanted upside down

Days went by and the girl's doctors never figured out what was wrong. When she was transferred to a different hospital, however, the issue was quickly identified and corrected. 

READ MORE >
A gavel and a stethoscope
Share on Twitter Share on Facebook Share on Linkedin

Family files $17M lawsuit after young girl’s heart valve allegedly implanted upside down

Share on Twitter Share on Facebook Share on Linkedin
A gavel and a stethoscope
Days went by and the girl's doctors never figured out what was wrong. When she was transferred to a different hospital, however, the issue was quickly identified and corrected. 
READ MORE >

In Other News

AI helps spot previously 'invisible' gray matter MS lesions

Although it's well-established that lesions in the brain’s gray matter play a significant role in the progression of multiple sclerosis, there has been no reliable way to visualize these abnormalities on imaging.

READ MORE >
AI helps spot invisible gray matter MS lesions
Share on Twitter Share on Facebook Share on Linkedin

AI helps spot previously 'invisible' gray matter MS lesions

Share on Twitter Share on Facebook Share on Linkedin
AI helps spot invisible gray matter MS lesions
Although it's well-established that lesions in the brain’s gray matter play a significant role in the progression of multiple sclerosis, there has been no reliable way to visualize these abnormalities on imaging.
READ MORE >

Ascension to buy Tennessee hospital as part of a $1B investment deal

One of the largest nonprofit health systems in the country is set to buy Williamson Health, a Tennessee-based regional hospital and provider network. If approved by regulators, the transaction could be finalized sometime next year. 

READ MORE >
merger.png
Share on Twitter Share on Facebook Share on Linkedin

Ascension to buy Tennessee hospital as part of a $1B investment deal

Share on Twitter Share on Facebook Share on Linkedin
merger.png
One of the largest nonprofit health systems in the country is set to buy Williamson Health, a Tennessee-based regional hospital and provider network. If approved by regulators, the transaction could be finalized sometime next year. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

AI is gaining ground, but clinicians run the show | Siemens Healthineers doubles down | Electrophysiologist compensation
News Alert: FDA shares warning about heart valve tech after patient death
Cardiologist pay & productivity are up | FDA clears PE thrombectomy devices | Cardiology tech in spotlight | Gore's new approval
Cardiology salaries on the rise | The climbing costs of care | M&A trends | Siemens Healthineers, J&J make big business moves
Major MRI trends | Blood thinner recalled | When to perform PCI before TAVR | How to build a CCTA program | Steroids & the heart
CMS boosts coverage for heart failure tech | FDA approves CardioMEMS updates | LVADs linked to strokes, other risks
M&A activity in cardiology: Exploring key trends | Cardiac PET vs. SPECT | Doctors support Medicare covering TAVR for AR
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme
Trimed Popup